Previous 10 | Next 10 |
SAN DIEGO , May 7, 2019 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today reported financial results for the first quarter ended March 31, 2019 and provided an update on recent corporate...
Halozyme Therapeutics (NASDAQ: HALO ) is scheduled to announce Q1 earnings results on Tuesday, May 7th, after market close. More news on: Halozyme Therapeutics, Inc., Earnings news and commentary, , Healthcare stocks news, Read more ...
ACLS , ADT , APEI , ATO , ATSG , AVD , AVLR , BECN , BOLD , CERS , CHUY , COLD , CRAY , CRZO , CSOD , CTRE , CWK , DDD , DIOD , DVA , EA , EDIT , ENTA , ESE , EVH , EVRI , FANG , FARM , FATE , FG , FLT , FTSI , GHDX , GTES , HALO , HCLP , HUBS , ICHR , ...
SAN DIEGO , May 6, 2019 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today announced the appointment of biotechnology and pharmaceutical industry expert Alison A. Armour , M.B. Ch.B., B....
Not for Distribution to U.S. Newswire Servicers or For Dissemination in the United States Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that it has qualified to trade on the OTCQX® Best Market. Halo Labs upgrades to O...
Not for Distribution to U.S. Newswire Servicers or For Dissemination in the United States Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that it has qualified to trade on the OTCQX® Best Market. Halo Labs upgrades to O...
Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you c...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. The U.S. will send a high-level delegation to Beijing next week as trade negotiatio...
SAN DIEGO , April 23, 2019 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, will webcast its Quarterly Update Conference Call for the first quarter 2019 on Tuesday, May 7 at 4:30 p.m. ET / 1:30 ...
SAN DIEGO , March 4, 2019 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, will participate in two upcoming investor conferences. The 39 th Annual Cowen Healthcare Conference on Monday, Mar...
News, Short Squeeze, Breakout and More Instantly...
Halozyme Therapeutics Inc. Company Name:
HALO Stock Symbol:
NASDAQ Market:
Halozyme Therapeutics Inc. Website:
Halozyme to Report Second Quarter 2024 Financial and Operating Results PR Newswire SAN DIEGO , July 23, 2024 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced it will release its second quarter 2024 financial and operating re...
2024-07-22 03:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...